Derrick Tang

Founder of Kynam Capital Management, LP, noted for his value-oriented investments and his commitment to high-quality businesses in niche markets.

Explore Derrick Tang's largest investments on Profit.com, including companies like Syndax Pharmaceuticals Inc, Celldex Therapeutics Inc, and Vaxcyte Inc, and their significance in his portfolio.

Derrick Tang’s portfolio updates are typically published quarterly through SEC 13F filings, which provide detailed information about their holdings, including recent buys and sells. Additionally, real-time updates on insider trades are available through Form 4 filings, offering a more timely view of their trading activity.

Derrick Tang currently invests in companies such as Syndax Pharmaceuticals Inc, Celldex Therapeutics Inc, and Vaxcyte Inc, focusing on sectors like Healthcare.

The largest holding in Derrick Tang’s portfolio is Syndax Pharmaceuticals Inc, accounting for 11.94% of their total investments.

One of Derrick Tang’s most profitable investments is Sutro Biopharma, which has generated a return of 379.44% over the past year.

As of 17 May 2026, Derrick Tang’s portfolio is valued at approximately $1.58B, based on the latest filings available on Profit.com.

Yes, you can use Profit.com to follow Derrick Tang’s portfolio and gain insights to build your own investment portfolio.

You can follow Derrick Tang’s portfolio updates on Profit.com, which provides notifications on the latest portfolio transactions as soon as they’re available.

Stay up-to-date with Derrick Tang’s latest trades by following their portfolio on Profit.com. Enable notifications to receive real-time alerts on their newest buy and sell transactions.